13F filing recap · Q2 2009

What did ValueAct Capital buy in Q2 2009?

Reported stock-position changes between this filing and the previous one.

Stock value

$2.23B

Positions

Estimated turnover

27.0%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

WSHWillis Group Holdings Plc$88.39Mreported value+3.44M shares IU1Immucor Inc$27.52Mreported value+2.00M shares SWYSafeway Inc$13.71Mreported value+673.3K shares IDCInteractive Data Corp$13.19Mreported value+570.0K shares IMA-PBInverness Medical Innovations, Inc.$10.35Mreported value+46.0K shares HOTStarwood Hotels & Resorts Worldwide Inc$4.44Mreported value+200.0K shares XRAYDentsply Sirona Inc.$3.36Mreported value+110.0K shares

Increased positions

VRXValeant Pharmaceuticals International, Inc.$437.99Mreported value+3.79M shares+28.6%TRIThomson Reuters Corporation$346.47Mreported value+1.22M shares+11.2%IMAInverness Medical Innovations, Inc.$95.49Mreported value+2.35M shares+716.1%

Reduced positions

BFHBread Financial Holdings, Inc.$152.93Mreported value-400.0K shares-9.7%

Exited positions

DRCDresser-Rand Group Inc.$85.95Mprior reported value-3.89M shares-100.0%GVHRGevity HR Inc$13.00Mprior reported value-3.29M shares-100.0%ROKRockwell Automation, Inc.$10.39Mprior reported value-475.7K shares-100.0%NTAPNetapp, Inc.$7.51Mprior reported value-506.0K shares